| Title : Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes - Covington_2008_Clin.Ther_30_499 |
| Author(s) : Covington P , Christopher R , Davenport M , Fleck P , Mekki QA , Wann ER , Karim A |
| Ref : Clin Ther , 30 :499 , 2008 |
| Abstract : Covington_2008_Clin.Ther_30_499 |
| ESTHER : Covington_2008_Clin.Ther_30_499 |
| PubMedSearch : Covington_2008_Clin.Ther_30_499 |
| PubMedID: 18405788 |
Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A (2008)
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
Clin Ther
30 :499
Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A (2008)
Clin Ther
30 :499